Health Condition 1: null- Patients of either gender in the age group of 30-65 years â?¢Patients with classical signs and symptoms of Prameh/Madhumeha Health Condition 2: E119- Type 2 diabetes mellitus without complications
Conditions
Interventions
Intervention1: Mustadi kwatha and Meshashringi Churna
: 40 ml kwatha and 5 gms Meshashringi Churna twice daily before breakfast/meal (empty stomach) will be administered orally with
plain water for
Sponsors
All India Institute Of ayurveda
Eligibility
Inclusion criteria
Inclusion criteria: Patients with classical signs and symptoms of Prameh/Madhumeha as stated below Prabhuta Mutrata, Avila Mutrata, Pipasadhikya, Alasya, Utsahahani, Kshudhadhikya, Pindikodveshthana, Karapadatala Suptata, Daurbalya, Nidradhikya and Purishabadhdhata. Criteria for diagnosis of DM by American Diabetes Association Patients with random blood sugar level (RBS) >200 mg/dl, or Fasting blood sugar (FBS) >126 mg/dl up to 375 mg/dl, or or Postprandial blood sugar (PPBS) >200 mg/dl up to 500 mg/dl, and Glycosylated haemoglobin > 6.5%. Newly /Early diagnosed cases to be included as per following criteria: Patients who are not taking any treatment for diabetes. Patients who are not taking any conventional medicine for more than two months, whose sugar levels are raised and fall within the inclusive criteria mentioned above and are willing to take Ayurvedic treatment Patient accidently diagnosed in routine check-up or when appeared with other complaints in the hospital. Early diagnosed diabetic patients (less than 1yrs of history) who are asymptomatic and not taking any pharmacological drugs since last two months.
Exclusion criteria
Exclusion criteria: Patients less than 30 years and more than 65 years Emergency cases in DM Patients having insulin dependent DM (IDDM) and receiving insulin (type 1) Excessive blood glucose: FBS > 375 mg/dl and PPBS > 500 mg/dl Chronic complications like microvascular and macrovascular. Patients with any anti-diabetic pharmacological drugs Patients reporting to be hypersensitive to any of the proposed trial drug.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Glycosylated haemoglobin (in %) â?? to be assessed at the beginning and at the end of the trial) 2. Blood sugar post parandial(in mg/dl) Timepoint: 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Blood sugar fasting and random (in mg/dl) 2. Urine routine and microscopic examination â??albumin,sugar,casts/crystals,epithelialcells,pus cells. 3. Haemogram with ESR, ketone bodies, Lipid Profile, Liver Function Test And Kidney Function Test Timepoint: 4 months | — |
Countries
India
Contacts
Public ContactDr Rashmi Tokas Rana
All India Institute of Ayurveda
Outcome results
None listed